Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 24, 2026VaccinesOpen Access

Nanotechnology-Based Cancer Vaccines: Translational Barriers and Emerging Strategies

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMuneera AnwerGriffith UniversityRRRifat RahmanGriffith University

Discussion

Loading...

Member takes

Implication

Review summarizes translational barriers and emerging strategies for cancer vaccines using nanotechnology.

Key Points

  • This review aims to explore the potential of nanotechnology in enhancing cancer vaccine efficacy while addressing translational challenges.
  • Discussion of nanoparticle platforms including lipid, polymeric, inorganic nanoparticles, and virus-like particles.
  • Examination of engineering strategies for cytosolic delivery and endosomal escape.
  • Overview of current clinical pipeline and emerging strategies in cancer nanovaccine development.
  • Nanoparticle platforms enhance antigen delivery and immunogenicity, facilitating better immune responses.
  • Key barriers include immunosuppressive tumour microenvironments and inefficient lymph node targeting.
  • Emerging strategies like personalized nanovaccines and mRNA platforms are promising for enhancing therapeutic efficacy.

Cite This Study

Anwer et al. (2026) studied this question.

synapsesocial.com/papers/6a12963748a0ea1665672d31https://doi.org/10.3390/vaccines14060463
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nanovaccines: Innovative Advances from Design Strategies to Clinical Translation2025 · 14 citations
  2. 2Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering2024 · 21 citations
  3. 3The role of therapeutic cancer vaccines in the modern immunotherapy era: State of the art with recent progress and future challenges2025 · 18 citations
  4. 4Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer2023 · 1,415 citations
  5. 5Advances and Challenges of Liposome Assisted Drug Delivery2015 · 2,653 citations